As per NAVADHI Market Research, the global pharmaceutical industry [4] will we worth USD 1.57 trillion by 2023.
Sanofi S.A. is a Paris based, French multinational pharmaceutical company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions.
The French drugmaker expected net income to increase by 3-5% in 2019 as it reported slightly higher-than-expected quarterly earnings propelled once again by its rare diseases Genzyme unit.
Sanofi’s fourth-quarter business net income was up 4.3 percent at constant exchange rates to 1.36 billion euros, while revenue rose 3.9 percent to 9 billion. Sales at Genzyme surged 37.4 percent.
Net sales in 2018 were €34,463 million, down 1.7% according to latest report. The decline is mainly due to diabetes and cardiovascular (DCV) business unit performance as unit sales were down by 11.3%.
Spanning over 36 pages and 31 exhibits, “Sanofi S.A. - Company Snapshot & SWOT Analysis” report provides value chain analysis, financial performance, business strategy and SWOT analysis for company.
*If Applicable.
Links
[1] https://www.marketresearchreports.com/countries/global[2] https://www.marketresearchreports.com/pharma-healthcare[3] https://www.marketresearchreports.com/company-reports-pharma-healthcare[4] https://www.marketresearchreports.com/navadhi/global-pharmaceuticals-industry-analysis-and-trends-2023